Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert CofiledCriticalWarner Lambert Co
Priority to DO2004001000ApriorityCriticalpatent/DOP2004001000A/en
Publication of DOP2004001000ApublicationCriticalpatent/DOP2004001000A/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
208000035475disorderDiseases0.000abstract1
150000003839saltsChemical class0.000abstract1
Landscapes
Peptides Or Proteins
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Se describen ciertos ?-aminnoácidos que se unen a la subunidad alfa-2-delta (a2?) de un canal de calico. Estos compuestos y sus sales farmacéuticamente aceptables don útiles en el tratamiento de diversos trastornos psiquiátricos, del dolor y otros.Certain? -Amino acids that bind to the alpha-2-delta (a2?) Subunit of a calcium channel are described. These compounds and their pharmaceutically acceptable salts are useful in the treatment of various psychiatric, pain and other disorders.
DO2004001000A2004-09-232004-09-23
AMINO ACIDS WITH AFFINITY FOR PROTEIN
DOP2004001000A
(en)
Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease.
Compounds derived from 3-oxo-isoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder.
Compounds derived from cyano-3-oxoisoindoline-1-carboxamide, modulators of the sodium channel nav1,7; pharmaceutical composition comprising said compounds; and use in the treatment of a pain disorder.